NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/22/2024
Back to search
Official data from USPTO
POWDERHALE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
POWDERHALE
ST13
US500000098286234Class
5, 10
Filing
98286234
Registration
7543028
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
10/22/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 10
Filing date
11/27/2023
Registration date
10/22/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/22/2024
Last transaction
10/22/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Wiltshire, GB
Examiner
PERRY, KIMBERLY
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Vectura Limited
Representatives
MOLLY B. MARKLEY YOUNG, BASILE, HANLON & MACFARLANE P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical preparationspowders for asthma inhalers; pharmaceutical preparationspowders for transdermal injection for the alleviation or prevention of painfor the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical and veterinary preparations for erectile dysfunction; pharmaceutical and veterinary preparations for chronic obstructive pulmonary disease; pharmaceutical and veterinary preparations for premature ejaculation; pharmaceutical and veterinary preparations for cystic fibrosis; pharmaceutical and veterinary preparations for female sexual dysfunction; medicaments for migraine; pharmaceutical and veterinary preparations for asthma
Class 10
Inhalers for medical purposessold empty; metered dose inhalers for medical purposessold empty; active dry powder inhalers for medical purposessold empty; passive dry powder inhalers for medical purposessold empty; nebulisers for respiration therapy; respirators for artificial respiration and parts and fittings for all the aforesaid goods
Publications
History of USPTO decisions and trademark events.
10 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2024
PUBO
PUBLISHED FOR OPPOSITION
08/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2024
DOCK
ASSIGNED TO EXAMINER
05/29/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/18/2024
NWAP
NEW APPLICATION ENTERED
11/30/2023
Continuous trademark protection
Get notified about every new filing that threatens POWDERHALE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.